NVDA gained a massive 197% since our AI first added it in November - is it time to sell? 🤔Read more

China to investigate hospital dying student found on search engine

Published 03/05/2016, 11:39
© Reuters. People sit in front of the company logo of Baidu at its headquarters in Beijing
BIDU
-

By Adam Jourdan

SHANGHAI (Reuters) - China's health ministry will investigate a hospital that a university student turned to for cancer treatment after seeking information on the Baidu Inc (O:BIDU) search engine, a state health commission said on Tuesday.

The student, Wei Zexi, 21, died last month of a rare form of cancer and China's Internet regulator said on Monday it would investigate Baidu over the case.

Wei had searched Baidu for the best place for treatment, finding a department under the Second Hospital of Beijing Armed Police Corps which offered an experimental treatment that ultimately failed, state media reported this week.

The health ministry, along with military health departments, would jointly investigate the hospital, the National Health and Family Planning Commission said in a short statement on its website.

The ministry did not give further details about the investigation but said the case had drawn widespread public attention.

Before dying, Wei accused Baidu online of promoting false medical information, and the hospital for misleading advertising in claiming a high success rate for the treatment, state radio said.

Baidu said in a statement it deeply regretted Wei's death, and it would fully cooperate with the investigation.

Reuters was not able to reach the hospital for comment.

Baidu's shares dropped sharply after the investigation was announced on fears it may hit its advertising revenues and that it could face a sharp response from regulators who are keenly sensitive to healthcare-related scandals.

In a separate statement, the ministry said an inter-agency team would be set up to crack down on hospital ticket "scalpers" and online healthcare touts, a grey market of buying and selling access to healthcare which has drawn public anger.

The healthcare system is plagued by touts trading appointment tickets outside hospitals and a murky world online of healthcare advertisements offering cheap medicine or access to unapproved or experimental procedures.

Reuters reported in April ticket touts were defying a crackdown launched at the beginning of the year, casting light on the scale of the challenge China faces as it looks to overhaul a creaking, under-funded public health system.

© Reuters. People sit in front of the company logo of Baidu at its headquarters in Beijing

The ministry said it would speed up reforms, improve regulatory systems and standardize how operators published information to "get rid of the soil in which ticket scalpers and online touts survive".

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.